Drugmaker had stalled large-scale projects in England but has now pledged investment at two sites, announced by Keir Starmer
Britain’s biggest drugmaker AstraZeneca has said it will invest £300m in the UK in a surprise U-turn after pausing large-scale projects last year.
The drugmaker had pulled back investments in Britain after becoming disillusioned with the business environment, including the availability of new medicines on the NHS and drug pricing.
